Show simple item record

dc.date.accessioned2020
dc.date.available2020
dc.date.issued2020
dc.identifier.govdocPAHO/EIH/HA/COVID-19/20-0004
dc.identifier.urihttps://iris.paho.org/handle/10665.2/52263
dc.description.abstractSince the onset of the COVID-19 pandemic, health systems around the world have focused on reorganizing healthcare services and prioritizing hospital beds and intensive care units to manage people with COVID-19. This has included the suspension or reduction of elective cancer care and clinical visits for assessment, diagnosis and management, except for high-risk cancer patients. It has been noted that people who have COVID-19 and an underlying condition such as cancer have higher mortality than those without cancer. In addition, people with cancer are more likely to have complications from COVID-19. Despite strategies to maintain health services such as hemodialysis, oncology, chemotherapy, and others, there has been a significant reduction in access to service for patients who were being diagnosed or treated for cancer, due to their high risk. Studies have demonstrated that delays in cancer diagnosis and treatment have an impact on the progression of cancer. This could lead to future peaks in mortality from potentially curable cancers, as a result of not receiving standard treatment. For this reason, cancer services should rapidly manage and avoid any cumulative delays in treatment and prevent an increase in avoidable deaths from cancer.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectNeoplasmsen_US
dc.subjectCoronavirusen_US
dc.subjectChronic Diseaseen_US
dc.subjectOncology Service, Hospitalen_US
dc.titleConsiderations for the Reorganization of Cancer Services during the COVID-19 Pandemic, 26 May 2020en_US
dc.typeProcedures, manuals, guidelinesen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/52218en_US
paho.contributor.departmentEvidence and Intelligence for Action in Health (EIH)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO